Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 26NIH 5NETWORK 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 5CNS 1

Conditions

Glioblastoma 13Gliosarcoma 11Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 7Adenocarcinoma of Lung 7Pancreatic Neoplasms 6Astrocytoma 6Squamous Cell Carcinoma of Head and Neck 5Rectal Neoplasms 5Lung Neoplasms 5Burkitt Lymphoma 5Breast Neoplasms 5Brain Neoplasms 5Urinary Bladder Neoplasms 4Sarcoma 4Prostatic Neoplasms 4Glioma 4Adenocarcinoma, Bronchiolo-Alveolar 4Vaginal Neoplasms 3Oropharyngeal Neoplasms 3Esophageal Neoplasms 3Triple Negative Breast Neoplasms 2Skin Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Mouth Neoplasms 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2

Interventions

Cisplatin 23Radiotherapy 22Cetuximab 17Magnetic Resonance Spectroscopy 12Radiotherapy, Intensity-Modulated 10Fluorouracil 10Specimen Handling 9Platinum 91,2-diaminocyclohexaneplatinum II citrate 9pembrolizumab 8Erlotinib Hydrochloride 8Docetaxel 8Carboplatin 8Paclitaxel 7Biopsy 7Bevacizumab 7Radiation 5(225)Ac-DOTA-c(RGDyK) 5Hydroxyurea 4Gefitinib 4Radiosurgery 3Immunoglobulin G 3Disulfides 3Chemotherapy, Adjuvant 3Capecitabine 3ixabepilone 2dehydroftorafur 2atezolizumab 2aldesleukin 2Vorinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NIH × Squamous Cell Carcinoma of Head and Neck × Radiation × Clear all
NCT02567422 2025-12-04

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
43 enrolled 16 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01711541 2023-06-07

Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
24 enrolled 12 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT00049283 2014-06-06

Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT00023959 2013-02-07

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00033449 2013-01-25

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡